Ira Duarte

Ira Duarte

EVP, Chief Financial OfficeratHeron Therapeutics, Inc. /De/· In proxies 2022–2025

Pay in FY2025+6% from the year before · Heron Therapeutics, Inc. /De/ stock -15.0% the same year

Ira Duarte was paid $1.6M in FY2025 (Dec), up 6%. Heron Therapeutics, Inc. /De/ stock fell 15.0% that year.

Pay$100 in the stock at the end of FY21 → $14
Pay is from the Summary Compensation Table of each Heron Therapeutics, Inc. /De/ proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Heron Therapeutics, Inc. /De/Public company · 4 yr
    • EVP, Chief Financial Officer2022 – Present · 4 yrStock in role -97%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?